Brunch & Learn
Innovative Formulations for Nanomedicine
September 19, 2023​ | Barcelona, Spain​

Overview

New drug substances and modalities have been a driving force behind innovation in formulation development. This success could not have happened without decades of biotechnology research and the discovery of excipients and technologies to enable effective drug delivery.

In this seminar we take you through two key examples in innovative formulation development:

  1. Lipids are one of the pillar excipients for drug delivery systems and are especially important for RNA-based therapies such as mRNA vaccines
  2. Long-acting injectables, particularly those based on microparticles, nanoparticles and implants, are among the most attractive parenteral products in the pharmaceutical industry
This event will be hosted by Evonik Health Care, featuring talks from Dr. Ulrich Kloeckner and Dr. Tom Tice and. We are also delighte to welcome guest speaker Alejandro Mahía Moros from Certest, who will present drug delivery insights from the perspective of a pharmaceutical company.


Key learnings for participants

  • Importance of control of lipid impurities and technologies needed for lipid manufacturing
  • Overview of poly(lactide-co-glycolide) polymer properties relevant to drug delivery formulations
  • History and backstories around long acting injectables and polymeric drug products on the market
  • Challenges in the GMP-production of implants, microparticles and nanoparticles


Please note:
Please fill in your details and click 'Submit' to register for the workshop of your choice. Once we receive your registration, we will send you a status notification as soon as possible. Due to the high demand for our workshops, we sometimes need to reject registrations or put you on a waiting list. Workshop materials will be available for download at the end of the workshop. Any photographs taken during the event are the property of Evonik and may be used for promotional purposes.

Details
Participation fee: Free of charge
Workshop language: English


Agenda
The workshop will start at 9:00 on Tuesday, September 19, 2023 and finish at 13:00 on the same day. To see the detailed workshop program please click here.


Venue
The workshop will take place at:

Fundació Parc Científic de Barcelona
Campus Diagonal - Universitat de Barcelona
Baldiri Reixac 10-12
08028 BARCELONA
37-REC-CM37 Evonik Meeting room


Fill out the form to register for the workshop:

AGENDA

09.00
Registration​

09.30
Welcome & Introduction​
George-William Smith (Senior Business Manager , Parenteral Drug Delivery Services)​
Javier Palacin (Senior Business Manager, Spain and Portugal)​

09.45
Leading the Way in Lipid Production
Ulrich Kloeckner (Global Project Manager)​

10.30
Networking Brunch ​

11.30
Bioabsorbable Long-Acting Injectables: History, Products and Future Trends ​
Tom Tice (Senior Director, Global Strategic and Technical Marketing )​

12:15
New families of ionizable lipids for effective delivery of RNA therapeutics
Alejandro Mahía Moros, Senior Researcher of Certest​

12:45
Wrap-Up and Goodbye ​ All



​
Disclaimer
Notice for business transactions
We assume that you are not currently or foreseeably involved in a business decision in favour of or in direct connection with the Evonik Group or, if this is the case, the decision will not be influenced by this invitation. Therefore, we do not see any concerns on our part regarding your participation. However, we would like to ask you to ensure that you are allowed to accept the invitation in accordance with the regulations that apply to you.

Note for public officials
We assume that you are not or have not been involved in any official act in favour of or in connection with the Evonik Group, either now or in the foreseeable future or in the past and therefore your participation in the event is not subject to any concerns. In addition, we ask you to ensure that your superior approves your participation or you may also accept the invitation in accordance with the rules applicable to you. By registering or participating, you confirm to us that the acceptance of this invitation is permitted according to your internal rules and that you have obtained all necessary approvals. If this is not the case, we ask you for a corresponding note.

Tax notices
Any tax liability resulting from this event will be borne by Evonik Industries AG through a flat-rate tax levy pursuant to Section 37b of the German Income Tax Act (EStG). If you are not taxable in Germany, please clarify whether you must report the invitation to your employer for taxation or whether taxation must be made via your income tax return.


QUESTIONS? 



George William Smith
Senior Business Manager/Parenteral Drug Delivery Services
+49 174 9092507
Email

Cléa Michel

Cléa Michel is product manager for Cell Culture Ingredients at Evonik Health Care. She provides biopharma companies and media manufacturers with the finest specialty ingredients to increase cell culture performance. Cléa has a background in biochemistry and biotechnology engineering and holds a master’s degree from the National Institute of Applied Sciences in Lyon, France. She has held various positions in marketing, project management and business development and is passionate about innovative solutions that enable the successful development of life-saving biopharmaceuticals.
Dr. Stephan Brinkmann

Stephan Brinkmann works as project manager and head of Evonik's Biopharma Applications group at Evonik R&D for the Health Care business line. He is responsible for biopharma innovation projects as well as application tests of Evonik's cell culture ingredients (i.e., cQrex® peptides). Stephan studied molecular biotechnology at Bielefeld University in Germany, where he specialized in biopharma upstream and downstream process development. Before joining Evonik, Stephan worked in Switzerland on industrial mammalian cell line development for the production of therapeutic biologics. Stephan obtained his Ph.D. in a public private partnership with Sanofi and later Evotec at Fraunhofer IME in Giessen with a focus on the discovery of natural products, especially peptides.